CLINICAL_TRIALS
research
· 2026-02-03
Clinical Trial Update: Maintenance ElectroConvulsive Therapy in Clozapine RESISTant Schizophrenia - the MECT-RESIST Trial [NA]
Summary
A clinical trial evaluating maintenance electroconvulsive therapy for clozapine-resistant schizophrenia, with recruitment ongoing.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Central Institute of Mental Health, Mannheim | Conditions: Schizophrenia, Treatment Resistant Schizophrenia | NA | Status: RECRUITING